Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 8INDUSTRY 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 185Neoplasms 111Breast Neoplasms 100Colorectal Neoplasms 90Ovarian Neoplasms 72Neoplasm Metastasis 70Prostatic Neoplasms 67Multiple Myeloma 63Lung Neoplasms 59Squamous Cell Carcinoma of Head and Neck 47Endometrial Neoplasms 46Recurrence 45Pancreatic Neoplasms 43Leukemia, Lymphocytic, Chronic, B-Cell 38Small Cell Lung Carcinoma 37Stomach Neoplasms 36Carcinoma, Renal Cell 36Melanoma 33Leukemia, Myeloid, Acute 32Urinary Bladder Neoplasms 28Triple Negative Breast Neoplasms 28Lymphoma, Non-Hodgkin 27Parkinson Disease 4, Autosomal Dominant Lewy Body 26Head and Neck Neoplasms 25Lymphoma, Follicular 24Carcinoma, Hepatocellular 24Lymphoma, Large B-Cell, Diffuse 23Esophageal Neoplasms 22Advanced Solid Tumors 22Lymphoma 21

Interventions

daromun 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Basal Cell × 30 days × Clear all
NCT07227350 2026-06-02

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Philogen S.p.A.

Phase 2 Recruiting
180 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT07600476 2026-05-20

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

Kupando GmbH

Phase 1 Recruiting
21 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡